For Burgeoning Emerging Markets, All Business is Local
This article was originally published in PharmAsia News
Executive Summary
With growth slowing to a crawl in their largest markets, most major drug firms are focusing significant resources in emerging markets - now providing roughly one-third of the industry's growth, double its share two years ago
You may also be interested in...
GSK Sees Emerging Market Opportunity In Thinking Locally, Developing Locally
U.K. drug maker is increasing its sales forces in emerging markets “very significantly”, even at a time when the company is reducing its sales force in U.S. and Europe.
GSK Sees Emerging Market Opportunity In Thinking Locally, Developing Locally
SINGAPORE - GSK APJEM R&D is pretty hefty as far as acronyms go, but GlaxoSmithKline's Judith Hills wants to make sure observers do not over look the research and development title in the new GSK division
GSK Sees Emerging Market Opportunity In Thinking Locally, Developing Locally
U.K. drug maker is increasing its sales forces in emerging markets “very significantly”, even at a time when the company is reducing its sales force in U.S. and Europe.